Efficacy of compound oxymatrine injection combination with postoperative chemotherapy for advanced ovarian carcinoma

Objective To evaluate the effect of compound oxymatrine injection combination with chemotherapy in patients with advanced ovarian carcinoma.Methods Eighty-six patients with advanced ovarian carcinoma were divided by random digits table method into observation group (43 cases) receiving compound oxymatrine injection plus chemotherapy (paclitaxel plus carboplatin) and control group (43cases) treated with chemotherapy (p aclitaxel plus carboplatin) alone.The change of white blood cell,adverse reaction and effect of the patients were observed.Results The white blood cell of observation group after treatment was obviously higher than that of control group [ (4.7 ± 1.4) × 109/L vs.(3.2 ± 1.6) × 109/L,P ＜ 0.05 ].The rates of nausea and vomiting,transaminase elevating and kidney damage of observation group were obviously lower than those of control group [ 16.3％ (7/43),14.0％ (6/43),20.9％ (9/43) vs.34.9％(15/43),32.6％ (14/43),44.2％ ( 19/43 ),P ＜ 0.05 ].The complete remission rate of observation group was significantly higher than that of control group [55.8％(24/43) vs.27.9％(12/43),P ＜ 0.05].Conclusion Addition of compound oxymatrine injection to chemotherapy for patients with advanced ovarian carcinoma can effectively protect patients against the decreasing of the white blood cell and attenuate the side effects brought by chemotherapy. Key words: Sophora flavescens; Ovarian neoplasms; Drug therapy